Sheryl Mitnick

FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial

Benjamin J Kim, T. Aleman, L. Schuchter, 2019, Retina.

Family Caregivers, Patients and Physicians: Ethical Guidance to Optimize Relationships

Sheryl Mitnick, 2010 .

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600 -mutant Melanoma

Benjamin J Kim, T. Aleman, G. Linette, 2022 .

Family Caregivers, Patients and Physicians: Ethical Guidance to Optimize Relationships

V. Hood, Sheryl Mitnick, Cathy Leffler, 2010, Journal of general internal medicine.

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma

Benjamin J Kim, T. Aleman, G. Linette, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas

C. Steidl, M. Lim, A. Maity, 2020, Haematologica.

Family Caregivers, Patients and Physicians: Ethical Guidance to Optimize Relationships

V. Hood, Sheryl Mitnick, Cathy Leffler, 2010, Journal of General Internal Medicine.

Family Caregivers, Patients and Physicians: Ethical Guidance to Optimize Relationships

Sheryl Mitnick, Mph Sheryl Mitnick RN, 2010, Journal of General Internal Medicine.